Christopher Gibson - Chief Executive Officer, Director at Recursion Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Stock Symbol
RXRX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Christopher Gibson - trading volume in the past year for Recursion Pharmaceuticals, Inc.

Holdings reported by Christopher Gibson for Recursion Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Class A Common Stock 759K $5.67M $7.47 Jul 11, 2024 Direct
Class B Common Stock 6.23M Jul 11, 2024 Direct Class A Common Stock 0
Stock Option (Right to Buy) 667K Jul 10, 2024 Direct Class A Common Stock 0
Class B Common Stock 486K Jul 10, 2024 by LAHWRAN-3 LLC Class A Common Stock 0
Class B Common Stock 388K Jul 10, 2024 by LAHWRAN-4 LLC Class A Common Stock 0
Class B Common Stock 67.9K Jul 10, 2024 by Gibson Family Trust Class A Common Stock 0

Transactions reported by Christopher Gibson for Recursion Pharmaceuticals, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership